- ¥50bn
- ¥127bn
- ¥67bn
- 50
- 63
- 98
- 84
Annual balance sheet for Cre, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 14,466 | 19,474 | 36,806 | 28,292 | 24,325 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 612 | 1,158 | 1,162 | 3,705 | 1,286 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 49,324 | 76,790 | 92,273 | 109,658 | 111,141 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,562 | 4,566 | 7,222 | 7,467 | 6,829 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 70,143 | 99,042 | 118,248 | 138,821 | 142,557 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28,039 | 14,976 | 20,695 | 35,357 | 39,373 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 50,140 | 72,379 | 82,096 | 100,365 | 101,452 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 20,003 | 26,663 | 36,152 | 38,456 | 41,105 |
Total Liabilities & Shareholders' Equity | 70,143 | 99,042 | 118,248 | 138,821 | 142,557 |
Total Common Shares Outstanding |